These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36237224)

  • 1. Saudi Heart Association Position Statement on the Use of Biomarkers for the Management of Heart Failure and Acute Coronary Syndrome.
    AlHabeeb W; Tash AA; Almutari F; Al Ghalayini K; Alqaseer M; Alshamiri M; Kharabsheh S; AlKashkari W
    J Saudi Heart Assoc; 2022; 34(2):114-123. PubMed ID: 36237224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saudi Heart Association Guidelines on Best Practices in the Management of Chronic Coronary Syndromes.
    AlShammeri O; Al Saif S; Al Shehri H; Alasng M; Qaddoura F; Al Shehri M; Turkistani Y; Tash A; Alharbi W; Al Qahtani F; Diaz R; Mahaimeed W; Al Habeeb W; Alfaraidy K
    J Saudi Heart Assoc; 2022; 34(3):182-211. PubMed ID: 36578770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptides in heart failure and acute coronary syndrome.
    Gaggin HK; Januzzi JL
    Clin Lab Med; 2014 Mar; 34(1):43-58, vi. PubMed ID: 24507786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
    Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
    Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics, management and outcomes of patients with chronic heart failure: Results from the heart function assessment registry trial in Saudi Arabia (HEARTS-chronic).
    Alhabeeb W; Elasfar A; AlBackr H; AlShaer F; Almasood A; Alfaleh H; Kashour T; Hersi A; Asfina KN; Altaradi H; AlShaqhaa W; Alayoubi F; AlHabib KF
    Int J Cardiol; 2017 May; 235():94-99. PubMed ID: 28284505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mid-regional pro-atrial natriuretic peptide for the early detection of non-acute heart failure.
    Gohar A; Rutten FH; den Ruijter H; Kelder JC; von Haehling S; Anker SD; Möckel M; Hoes AW
    Eur J Heart Fail; 2019 Oct; 21(10):1219-1227. PubMed ID: 31209992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saudi Heart Association (SHA) guidelines for the management of heart failure.
    AlHabeeb W; Al-Ayoubi F; AlGhalayini K; Al Ghofaili F; Al Hebaishi Y; Al-Jazairi A; Al-Mallah MH; AlMasood A; Al Qaseer M; Al-Saif S; Chaudhary A; Elasfar A; Tash A; Arafa M; Hassan W
    J Saudi Heart Assoc; 2019 Oct; 31(4):204-253. PubMed ID: 31371908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers and diagnostics in heart failure.
    Gaggin HK; Januzzi JL
    Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the Addition of NT-proBNP and Glucose Measurements Improve the Prognostication of High-Sensitivity Cardiac Troponin Measurements for Patients with Suspected Acute Coronary Syndrome?
    Kavsak PA; Mondoux SE; Hewitt MK; Ainsworth C; Hill S; Worster A
    J Cardiovasc Dev Dis; 2021 Sep; 8(9):. PubMed ID: 34564124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome.
    Dong M; Liao JK; Yan B; Li R; Zhang M; Yu CM
    Int J Cardiol; 2013 Sep; 167(6):2813-9. PubMed ID: 22921817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP.
    Leto L; Testa M; Feola M
    Minerva Cardioangiol; 2016 Apr; 64(2):157-64. PubMed ID: 26373781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial.
    Sharma A; Vaduganathan M; Ferreira JP; Liu Y; Bakris GL; Cannon CP; White WB; Zannad F
    J Am Heart Assoc; 2020 Jan; 9(1):e012797. PubMed ID: 31902327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing sensitivity and specificity of the Manchester Triage System in the evaluation of acute coronary syndrome in adult patients in emergency care: a systematic review protocol.
    Nishi FA; de Motta Maia FO; de Lopes Monteiro da Cruz DA
    JBI Database System Rev Implement Rep; 2015 Nov; 13(11):64-73. PubMed ID: 26657465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute heart failure with and without acute coronary syndrome: clinical correlates and prognostic impact (From the HEARTS registry).
    AlFaleh H; Elasfar AA; Ullah A; AlHabib KF; Hersi A; Mimish L; Almasood A; Al Ghamdi S; Ghabashi A; Malik A; Hussein GA; Al-Murayeh M; Abuosa A; Al Habeeb W; Kashour TS
    BMC Cardiovasc Disord; 2016 May; 16():98. PubMed ID: 27206336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-TerminaL PRO-BNP in Acute Coronary Syndrome Patients with ST Elevation Versus Non ST Elevation in Qassim Region of Saudi Arabia.
    Salama RH; El-Moniem AE; El-Hefney N; Samor T
    Int J Health Sci (Qassim); 2011 Jul; 5(2):136-45. PubMed ID: 23267291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.
    Gaggin HK; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Walters EL; Januzzi JL;
    Am Heart J; 2017 Oct; 192():26-37. PubMed ID: 28938961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of NT-proBNP in Patients With Successful PCI for ACS and Normal Left Ventricular Ejection Fraction.
    Wang JL; Guo CY; Li HW; Zhao XQ; Zhao SM
    Am J Med Sci; 2022 Apr; 363(4):333-341. PubMed ID: 34986361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma amino-terminal pro-brain natriuretic peptide levels in subjects presenting to the Emergency Department with suspected acute coronary syndrome: possible role in selecting patients for follow up?
    Campbell DJ; Munir V; Hennessy OF; Dent AW
    Intern Med J; 2001; 31(4):211-9. PubMed ID: 11456034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study.
    Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Hansen PM; Kamstrup PR; Faber J; Køber L; Schou M
    Biomarkers; 2020 May; 25(3):248-259. PubMed ID: 32126847
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(2):1-125. PubMed ID: 34055110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.